John Menditto | executive |
David Mazzo | executive |
James Nisco | executive |
Kristen Buck | executive |
Sara Nik | analyst |
Peter Enderlin | analyst |
David Slack | executive |
Stephen Brozak | analyst |
Shubhendu Sen Roy | analyst |
Welcome to the Lisata Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Business Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, Thursday, March 30, 2023. I will now turn the call over to John Menditto, Vice President of Investor Relations and Corporate Communication at Lisata. Please go ahead, sir.
Thank you, operator, and good afternoon, everyone.